A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)-Reference-Cited by-同舟云学术

A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)

Published:2023-12 Issue: Volume:11 Page:100505
ISSN:2352-0477
Container-title:European Journal of Radiology Open
language:en
Short-container-title:European Journal of Radiology Open

Author:

Cappello Giovanni,Giannini Valentina,Cannella Roberto,Tabone Emanuele,Ambrosini Ilaria,Molea Francesca,Damiani Nicolò,Landolfi Ilenia,Serra Giovanni,Porrello Giorgia,Gozzo Cecilia,Incorvaia Lorena,Badalamenti Giuseppe,Grignani Giovanni,Merlini Alessandra,D’Ambrosio Lorenzo,Bartolotta Tommaso Vincenzo,Regge Daniele

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up;Casali;Ann. Oncol. J. Eur. Soc. Med Oncol.,2022

2. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal;Kindblom;Am. J. Pathol.,1998

3. Prognostic indicators for gastrointestinal stromal tumors: a review;Zhang;Transl. Oncol.,2020

4. Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path;Machairiotis;J. Multidiscip. Health,2013

5. Gastrointestinal stromal tumours: origin and molecular oncology;Corless;Nat. Rev. Cancer,2011

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bag-of-Words Algorithm to Predict Response to Treatment in Gist Tumors Using CT Scans;2024 IEEE International Symposium on Biomedical Imaging (ISBI);2024-05-27